These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 6191299
1. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation. Morady F, Scheinman MM, Hess DS. Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299 [Abstract] [Full Text] [Related]
2. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. McGovern B, Garan H, Malacoff RF, DiMarco JP, Grant G, Sellers TD, Ruskin JN. Am J Cardiol; 1984 Jun 01; 53(11):1558-63. PubMed ID: 6731300 [Abstract] [Full Text] [Related]
3. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Morady F, Sauve MJ, Malone P, Shen EN, Schwartz AB, Bhandari A, Keung E, Sung RJ, Scheinman MM. Am J Cardiol; 1983 Nov 01; 52(8):975-9. PubMed ID: 6637851 [Abstract] [Full Text] [Related]
4. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. Heger JJ, Prystowsky EN, Zipes DP. Am Heart J; 1983 Oct 01; 106(4 Pt 2):887-94. PubMed ID: 6613835 [Abstract] [Full Text] [Related]
5. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease. Yazaki Y, Haffajee CI, Gold RL, Bishop RL, Alpert JS. Am J Cardiol; 1987 Aug 01; 60(4):293-7. PubMed ID: 3618488 [Abstract] [Full Text] [Related]
6. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN. Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357 [Abstract] [Full Text] [Related]
7. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal. Lavery D, Saksena S. Am Heart J; 1987 Jan 01; 113(1):49-56. PubMed ID: 3799441 [Abstract] [Full Text] [Related]
8. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia. Saksena S, Rothbart ST, Shah Y, Cappello G. Am J Cardiol; 1984 Aug 01; 54(3):347-52. PubMed ID: 6465016 [Abstract] [Full Text] [Related]
9. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone. Strasberg B, Kusniec J, Zlotikamien B, Mager A, Sclarovsky S. Am J Cardiol; 1990 Sep 15; 66(7):673-8. PubMed ID: 2399883 [Abstract] [Full Text] [Related]
10. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia. Veltri EP, Reid PR, Platia EV, Griffith LS. Am J Cardiol; 1985 Feb 01; 55(4):375-9. PubMed ID: 3969872 [Abstract] [Full Text] [Related]
11. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome. Bhandari AK, Hong R, Au P, McKay CR, Rahimtoola SH. Can J Cardiol; 1988 Mar 01; 4(2):80-4. PubMed ID: 3365601 [Abstract] [Full Text] [Related]
12. Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy. Reddy CP, Kuo CS, Jivrajka V. Pacing Clin Electrophysiol; 1984 Nov 01; 7(6 Pt 1):1055-62. PubMed ID: 6209624 [Abstract] [Full Text] [Related]
13. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent. Singh BN. Am J Cardiol; 1996 Aug 29; 78(4A):41-53. PubMed ID: 8780328 [Abstract] [Full Text] [Related]
14. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables. DiCarlo LA, Morady F, Sauve MJ, Malone P, Davis JC, Evans-Bell T, Winston SA, Scheinman MM. Am J Cardiol; 1985 Feb 01; 55(4):372-4. PubMed ID: 3969871 [Abstract] [Full Text] [Related]
15. Clinical significance of nonclinical ventricular tachycardia induced in amiodarone-treated patients. Belhassen B, Shapira I, Keren G, Laniado S. Eur Heart J; 1985 Mar 01; 6(3):266-75. PubMed ID: 4029184 [Abstract] [Full Text] [Related]
16. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment. Schmitt C, Brachmann J, Waldecker B, Rizos I, Senges J, Kübler W. Am Heart J; 1987 Aug 01; 114(2):279-83. PubMed ID: 3604883 [Abstract] [Full Text] [Related]
17. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Fogoros RN, Anderson KP, Winkle RA, Swerdlow CD, Mason JW. Circulation; 1983 Jul 01; 68(1):88-94. PubMed ID: 6851057 [Abstract] [Full Text] [Related]
18. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery. Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A. G Ital Cardiol; 1999 Oct 01; 29(10):1142-56. PubMed ID: 10546124 [Abstract] [Full Text] [Related]
19. Ventricular arrhythmias: use of electrophysiologic studies. Horowitz LN, Spielman SR, Greenspan AM, Webb CR, Kay HR. Am Heart J; 1983 Oct 01; 106(4 Pt 2):881-6. PubMed ID: 6613834 [Abstract] [Full Text] [Related]
20. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest. Morady F, Scheinman MM, Hess DS, Sung RJ, Shen E, Shapiro W. Am J Cardiol; 1983 Jan 01; 51(1):85-9. PubMed ID: 6849269 [Abstract] [Full Text] [Related] Page: [Next] [New Search]